Related Experiment Video
Updated: May 30, 2026

09:31
Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
Longevity of human islet α- and β-cells
M Cnop1, M Igoillo-Esteve, S J Hughes
1Laboratory of Experimental Medicine, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Diabetes, Obesity & Metabolism
|August 10, 2011
Summary
Human islet cells, crucial for diabetes and cell therapy, show limited regeneration after age 20. Understanding age-related senescence is key to inducing islet cell regeneration.
Area of Science:
- Endocrinology
- Cell Biology
- Regenerative Medicine
Background:
- Pancreatic islet cell regeneration is vital for diabetes onset, progression, and cell therapy.
- Rodent studies suggest continuous α- and β-cell turnover and plasticity, responding to metabolic demands.
- Human islet cell plasticity appears limited compared to rodents, with reduced regenerative capacity in aging.
Purpose of the Study:
- To investigate the plasticity and longevity of human pancreatic islet cells (α- and β-cells) in relation to aging.
- To understand the mechanisms underlying the age-related decline in islet cell regeneration.
- To identify factors hindering the induction of human islet cell regeneration for therapeutic purposes.
Main Methods:
- Analysis of morphometric data from postmortem human pancreases.
- Measurement of β-cell longevity using carbon-14 ((14)C) dating and bromo-deoxyuridine (BrdU) incorporation.
- Quantitative estimation and mathematical modeling of cellular lipofuscin body content in human islets across a wide age range (1-84 years).
- Assessment of age-related changes in proteins associated with cell division (e.g., cyclin D3, PDX-1).
Main Results:
- Human β-cells have a longevity of over 20-30 years, with 97% of the population established by age 20.
- Age-related decline in cell division and regeneration markers (cyclin D3, PDX-1) was observed.
- Lipofuscin accumulation, a marker of aging, increases with age in both α- and β-cells, with ≥95% of cells showing lipofuscin after 20 years.
- Human islet cell expansion in obesity is less pronounced than in rodents.
Conclusions:
- Human pancreatic islet cell populations are largely established by age 20 and exhibit limited plasticity and regeneration thereafter.
- Age-related senescence, potentially linked to organelle turnover (mitochondria, endoplasmic reticulum), limits human islet cell regenerative potential.
- Further research into age-related senescence mechanisms is necessary to develop strategies for inducing human islet cell regeneration for diabetes therapy.
Related Concept Videos
Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
